搜索优化
English
全部
搜索
图片
视频
地图
资讯
Copilot
更多
购物
航班
旅游
酒店
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 1 小时
时间不限
过去 24 小时
过去 7 天
过去 30 天
最佳匹配
最新
资讯
23 分钟
智氪 | 一季度狂揽50亿刀,替尔泊肽凭什么成为减肥顶流?
诺和诺德司美格鲁肽是近年来的一款“网红药物“,在介入减肥领域后,凭借其优秀的药效和名人的示范效应,一时风头无两。礼来的同类型药物替尔泊肽作为后起之秀,在近两年的表现亦颇为亮眼,曝光度不次于司美格鲁肽。
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
Central Texas flash floods
How to help TX flood victims
To end protected status
Alleged killer dad spotted?
Review finds no 'client list'
Grays Ferry mass shooting
Bees attack French town
Announces comeback
Terrorist designation lifted
TX Border Patrol shooting
US kids getting unhealthier?
Medical groups file suit
Guilty in mushroom case
Arrested on 2 charges
Trump defends Bolsonaro
To put 25% tariffs on JP, SK
Cleared of doping charge
Golfer Ed Fiori dies
North Carolina floods
Nationals fire manager, GM
Russia's ex-minister dies
Out of Tour de France
US wins AmeriCup
Mexico wins Gold Cup title
Indonesian volcano erupts
Advances to quarterfinals
Capgemini to buy WNS
Apple challenges EU fine
SVG wins in Chicago
Cases reach record high
反馈